Automated Chemiluminescent Immunoassay Analyzing System
for detection of COVID-19 antibodies
Sophonix MS-Fast is a fully automatic chemiluminescence immunoassay analyzing system that, when used in combination with the BioCheck SARS-CoV-2 IgM and IgG Antibody Test kits, can qualitatively detect the content of SARS-CoV-2 IgM and IgG antibodies in human serum samples. The Sophonix MS-Fast analyzer and BioCheck SARS-CoV-2 Antibody Test kits are for in vitro diagnostic use in the United States under FDA Emergency Use Authorization.
Instrument runtime: : approx. 30 minutes
Throughput/Capacity: up to 8 samples per run
Scalable, affordable benchtop model
Excellent specificity and sensitivity compared to ELISA and lateral flow tests
Have questions about our COVID-19 products? Get Answers
SARS-COV-2 IgM and IgG
The BioCheck SARS-CoV-2 IgM and IgG Antibody Test kits use chemiluminescent immunoassays to qualitatively detect the content of SARS-CoV-2 IgM and IgG antibodies in human serum samples.Learn about BioCheck SARS-CoV-2 tests
The analyzer uses indirect chemiluminescence based on chemiluminescent substrate (APS-5) and alkaline phosphatase, and is used together with the supporting detection reagents in the BioCheck SARS-CoV-2 tests to detect IgM and IgG antibodies that confirm exposure and indicate potential immunity to COVID-19.
Accelerate Diagnostics distributes the Sophonix MS-Fast system and BioCheck SARS-CoV-2 tests.
Ordering MS-FastAccelerate Diagnostics distributes the Sophonix MS-Fast analyzer and BioCheck SARS-CoV-2 tests in North America.
The Sophonix MS-Fast Analyzer and BioCheck SARS-CoV-2 IgM and IgG Antibody Test Kits are for in vitro diagnostic use in the United States under FDA Emergency Use Authorization.
US Product Number: T-1001
Customers outside the US: contact us for more information. Order your MS-Fast analyzer